Internet Archive Scholar

MSIA--SRM assay for parathyroid hormone and vitamin D binding protein: correlation with clinical immunoassay methods and application to clinical samples

Caje Moniz, Lewis Couchman, Bryan Krastins, Mary Lopez, Amol Prakash, David Sarracino, Mary Vogelsang, Scott Peterman, Gouri Vadali, Sarah Robinson
2013 Endocrine Abstracts  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (2.1 MB)
https://web.archive.org/web/20170809063927/http://www.endocrine-abstracts.org/ea/0031/eposters/ea0031p41_eposter.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL. The file type is application/pdf.

We have developed multiplexed, high-throughput, quantitative and precise SRM assays for both PTH and VDBP. The MSIA-SRM approach allows rapid and automated enrichment to achieve high sensitivity (ng/L) and selectivity. Simultaneous monitoring of intact and variant PTH species allows the precise quantification of active and inactive forms. Correlation of the PTH MSIA-SRM assay using only the N-terminal peptide (aa 1-13) with the traditional immunoassay confirms that commercial immunoassays
more » ... timate the amount of active PTH. Further, no evidence for PTH(7-84) was found in the data set. Further work will validate the utility of VDBP measurement in the routine assessment of vitamin D status.
doi:10.1530/endoabs.32.p156 fatcat:rzlnpuuwcrd77cmmwsgvqijy64
Citation

Caje Moniz, Lewis Couchman, Bryan Krastins, Mary Lopez, Amol Prakash, David Sarracino, Mary Vogelsang, Scott Peterman, Gouri Vadali, Sarah Robinson. "MSIA--SRM assay for parathyroid hormone and vitamin D binding protein: correlation with clinical immunoassay methods and application to clinical samples." Endocrine Abstracts (2013)